Abstract:Loss‐ and gain‐of‐function cardiac Na+ channel (SCN5A) mutations are associated with the Brugada and long QT type 3 syndromes (LQT3), respectively. Both result in ventricular arrhythmias, but have differing atrial effects. We have recently reported decreased incidences of atrial arrhythmias in a murine Scn5a+/Δ cardiac system used to model LQT3. We now explore for atrial arrhythmias in a murine Brugada syndrome model. Programmed electrical stimulation and burst pacing were applied to 10 wild‐type (WT) and 10 Scn5a+/− Langendorff‐perfused murine hearts. These induced arrhythmias in similar proportions of the Scn5a+/− and WT hearts, in contrast to their decreased incidences previously reported for Scn5a+/Δ. Almost half of the Scn5a+/− hearts displayed spontaneous atrial arrhythmias never observed in WT. Both these WT and Scn5a+/− hearts showed positive critical intervals, given by the difference between action potential durations at 90% recovery (APD90) and atrial effective refractory periods, before pharmacological intervention. Both flecainide and quinidine then prevented both induced and spontaneous atrial arrhythmias in all the arrhythmic WT and Scn5a+/− hearts, in contrast to their differing ventricular effects. However, flecainide prolonged APD90 in WT but not Scn5a+/−, whereas quinidine prolonged APD90 in both WT and Scn5a+/−. Nevertheless, addition of both agents markedly increased atrial effective refractory periods to values exceeding the corresponding values of APD90. This resulted in negative critical intervals in both WT and Scn5a+/−. These findings demonstrate a clear‐cut relationship between critical interval and atrial arrhythmic tendency for the first time and extend previous reports that had related critical interval to ventricular arrhythmia.

Experimental Physiology –research Paper: Atrial Arrhythmogenic Properties in Wild‐type and Scn5a+/− Murine Hearts